|
Specialty
introduces 18 additional assays and panels for enhanced autoantibody
testing.
Specialty, a leader in innovative neurology testing for
years, is pleased to announce that it will once again perform
a full spectrum of neurology autoantibody testing. These tests
will be available effective October 5, 2004.
Specialty 's Newly Available Neurology menu offers:
- Improved Turnaround times -- Results in 1 to 4 days
- Smaller minimum sample volumes on most assays
- Competitive pricing -- See your Specialty Representative
for price list
- Responsive Client Services support 24 hours a day/7 days
a week
- Third party billing for hundreds of contracted payers
These autoantibodies and expanded panels include:
 GM1 |
Yo |
Ganglioside
Autoantibodies Evaluation |
| Asialo-GM1 |
Hu |
Ganglioside
Triple Evaluation |
| GD1a |
Ri |
Paraneoplastic
Syndrome Evaluation |
| GD1b |
VGCC |
Paraneoplastic
Syndrome Evaluation with VGCC |
| GQ1b |
MAG |
|
| GM2 |
SGPG |
|
For more information, you may refer to the documents on the right
or contact Client Services at 800-421-4449. |
